Relugolix for the treatment of uterine fibroids

Expert Opinion on Pharmacotherapy
M L RoccaRoberta Venturella

Abstract

Uterine fibroids (UF) are benign tumors common in premenopausal women, with strong impact on the health-care systems. For many years, surgery represented the only therapy for symptomatic fibroids. However, clinicians are observing a switch from surgery to noninvasive methods; in particular, medical treatment has been shown to be efficacious in obtaining a bleeding reduction and in ameliorating patient conditions. The authors review the current options available for the treatment of women with UF, with a special focus on the newest one, relugolix. It is an orally active non-peptide Gonadotropin-releasing hormone (GnRH)-receptor antagonist recently licensed for women with symptomatic fibroids. Relugolix is a well-tolerated safe drug; it is effective in inducing a dose-dependent decrease in menstrual blood loss, with faster reduction of heavy menstrual bleeding (HMB) and a greater shrinkage in fibroid volume compared to the current standard of GnRH agonist treatment. Relugolix is a promising drug for the non-surgical treatment of women with UF. To date, the only published data come from a well-selected Japanese female population study while results from worldwide ongoing studies are ongoing in order to confirm the efficacy of this...Continue Reading

References

Nov 1, 1996·Human Reproduction·F J Broekmans
May 10, 2001·Clinical Obstetrics and Gynecology·M M Guarnaccia, M S Rein
Dec 26, 2001·Carcinogenesis·C L WalkerB Davis
Jan 28, 2003·American Journal of Obstetrics and Gynecology·Donna Day BairdJoel M Schectman
Sep 8, 2005·Expert Opinion on Investigational Drugs·Askan Schultze-MosgauKlaus Diedrich
Oct 20, 2006·Best Practice & Research. Clinical Obstetrics & Gynaecology·B C Tarlatzis, E M Kolibianakis
Mar 29, 2008·Best Practice & Research. Clinical Obstetrics & Gynaecology·Sahana GuptaIsaac Manyonda
Aug 14, 2009·The New England Journal of Medicine·Scott C Goodwin, James B Spies
Jul 27, 2011·Human Reproduction Update·Pasquapina CiarmelaMario Castellucci
Jan 17, 2012·American Journal of Obstetrics and Gynecology·Eden R CardozoJames H Segars
Feb 3, 2012·The New England Journal of Medicine·Jacques DonnezUNKNOWN PEARL I Study Group
Feb 3, 2012·The New England Journal of Medicine·Jacques DonnezUNKNOWN PEARL II Study Group
Apr 6, 2013·Fertility and Sterility·Md Soriful IslamPasquapina Ciarmela
Oct 4, 2013·The New England Journal of Medicine·Serdar E Bulun
Mar 19, 2014·Fertility and Sterility·Jacques DonnezUNKNOWN PEARL III and PEARL III Extension Study Group
Apr 23, 2014·Current Opinion in Obstetrics & Gynecology·Natalie A ClarkJames H Segars
Dec 30, 2014·Fertility and Sterility·Jacques DonnezErnest Loumaye
Apr 23, 2015·The New England Journal of Medicine·Elizabeth A Stewart
Dec 3, 2015·Clinical Obstetrics and Gynecology·James B Spies
Dec 30, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Errico ZupiFelice Petraglia
Jan 5, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Aaron K Styer, Bo R Rueda
Jan 13, 2016·Clinical Obstetrics and Gynecology·Chantal B BartelsJames H Segars
Jul 29, 2016·Human Reproduction Update·Jacques Donnez, Marie-Madeleine Dolmans
Nov 4, 2017·Seminars in Reproductive Medicine·James H Segars, Ayman Al-Hendy
Nov 4, 2017·Seminars in Reproductive Medicine·Ayman Al-HendyElizabeth Stewart
Nov 4, 2017·Seminars in Reproductive Medicine·Kristof Chwalisz, Hugh Taylor
Sep 9, 2018·Drugs·Yvette N Lamb
Jan 3, 2019·Climacteric : the Journal of the International Menopause Society·J DonnezM-M Dolmans
Apr 3, 2019·Drugs·Anthony Markham
May 30, 2019·The Journal of Obstetrics and Gynaecology Research·Marie-Madeleine DolmansLatifa Fellah
Jun 5, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Tomasz ŁozińskiMichał Ciebiera
Aug 29, 2019·Drugs of Today·F BarraS Ferrero
Jan 24, 2020·The New England Journal of Medicine·William D SchlaffOzgul Muneyyirci-Delale
May 5, 2020·Endocrine Reviews·Md Soriful IslamJames Segars

❮ Previous
Next ❯

Citations

Apr 18, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Gizem Kayki-Mutlu, Martin C Michel
May 29, 2021·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Inmaculada NicolásFrancisco Carmona

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Anita Slomski
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
© 2021 Meta ULC. All rights reserved